Tag: 2020

A CBS17 news report says antibody treatment for high-risk patients fighting COVID-19 is now available in central North Carolina, but there is a limited supply of the medication.  David Wohl, MD, professor in the division of infectious diseases, told CBS17 that it is being prioritized for people who have the...

Division of Gastroenterology & Hepatology Balfour Sartor, MD, and Shehzad Sheikh, MD, PhD, are co-principal investigators of a $2 million grant from the Helmsley Charitable Trust to conduct translational research that will predict recurrence after surgery for Crohn’s disease. Division of Nephrology and Hypertension Amy Mottl, MD, MPH, is receiving a five-year...

John Batsis, MD, associate professor of medicine in the division of geriatric medicine, has published the following papers: “Intensive nutrition counseling as part of a multi-component weight loss intervention improves diet quality and anthropometrics in older adults with obesity,” in Clinical Nutrition ESPEN. “Telemedicine in Long-Term Care Facilities During and...

Following is a list of cardiology authors and their recently published papers: Lindsey Rosman, PhD, and Anil Gehi, MD, published “When Smartwatches Contribute to Health Anxiety in Patients with Atrial Fibrillation” in the Cardiovascular Digital Health Journal. Lindsey Rosman, PhD, and Anil Gehi, MD, also published “How to stay healthy...

Miranda Van Tilburg, PhD, associate professor of medicine in the division of gastroenterology and hepatology, published “Paediatric Functional Abdominal Pain Disorders” in Nature Reviews Disease Primers. Paediatric functional abdominal pain disorders, currently referred to as disorders of gut–brain interaction, comprise irritable bowel syndrome, functional dyspepsia, abdominal migraine and functional abdominal...

Brian P. Kelley, MD, an internal medicine resident, Casey Gazda, MD, a fellow in cardiology, and Joseph A. Siyak, MD, assistant professor in cardiology, published “Loeffler Endocarditis as a Manifestation of Paraneoplastic Hypereosinophilia” in a recent issue of CASE, Cardiovascular Imaging Case. Eosinophilic myocarditis (EM) represents a rare spectrum of...

The new ‘Inpatient Cardiology Consult for Adult Congenital Heart Disease’ will follow patients with congenital defects and lead all inclusive care. UNC cardiologists ask that consults be made within 24 hours of admission. Coordinator Lunise Benjamin, DNP, NP-C, will be the main point of contact for the new program. As medical...

Infectious disease experts David Wohl, MD, Cameron Wolfe, MBBS (Duke University Health), and Chris DeRienzo, MD, MPP (WakeMed), discuss what they’re seeing at area hospitals during the pandemic and ways to slow the surge in new coronavirus infections. See this 30-minute round-table Zoom discussion hosted by WRAL, featuring Wohl, professor...

For his years of work studying infectious diseases and his role in helping North Carolina health professionals and residents respond to the pandemic, David Wohl, MD, is the News & Observer’s November Tar Heel of the Month, which honors people who have made significant contributions to North Carolina and the region.  Read the story...

The national AIDS Clinical Trials Group expanded its annual recognition program in 2020 with two new awards named for University of North Carolina faculty members who died in 2019: Charles van der Horst, MD, an infectious diseases physician and researcher, and Kevin Robertson, PhD, a professor of neurology and director of UNC’s...

Clinically, the division of endocrinology and metabolism provides outpatient care for patients with diabetes, obesity, bone disease, thyroid and parathyroid conditions, gender issues and other endocrine disorders at the UNCH Diabetes and Endocrinology Clinic at Meadowmont.  Led by Dr. Josh Evron, our thyroid and endocrine tumor service line includes a...

News of Oxford University and AstraZeneca‘s successful COVID-19 vaccine trial is inspiring increased optimism within the medical community. “We need billions of doses. And different vaccines have different upsides and downsides. Like the newest one we heard about yesterday, AstraZeneca. It’s easier to manufacture. So there (are) more doses that can...